ATH
Click for more information
20.0% 0.4¢ alterity therapeutics limited

Ann: First Patient Enrolled in USA in Phase II Clinical Trial, page-2

  1. brryh
    188 Posts.
    lightbulb Created with Sketch. 50
    clock Created with Sketch.
    16/03/23
    14:17
    Post #: 66803115
    Wonder if that first patient was a participant in The Bio Muse Study?
    ATH Price at posting: 0.8¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

THR Thor reports 200% increase in tungsten at NT's Molyhil
right-arrow Created with Sketch.
CCO Calmer Co taps investors for $2M
right-arrow Created with Sketch.
TLG Talga shows expansion options for Sweden's Vittangi graphite project
right-arrow Created with Sketch.
SPA Spacetalk makes European Market Reentry with Elisa
right-arrow Created with Sketch.
EDE Record shale gas and fracking drives demand for Eden's Optiblend in the USA
right-arrow Created with Sketch.
LU7 Lithium Universe inks final layout for Becancour lithium plant as DFS rolls on
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢ 		Change
-0.001(20.0%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $18 4.4K

Buyers (Bids)

No. Vol. Price($)
49 60387657 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 31704802 12
View Market Depth
Last trade - 10.55am 05/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.